Contrast-enhanced ultrasound
Updates to Article Attributes
Contrast-enhanced ultrasound (CEUS) involves the administration of intravenous contrast agents consisting of microbubbles/nanobubbles of gas.
First-generation ultrasound contrast agents contained microbubbles of air that were dissolved in blood when exposed to acoustic pressure in the ultrasound field. First-generation contrast agent hence were present in bloodstream for a limited time 1.
Second-generation contrast agents include microbubbles of perfluorocarbon, nitrogen gas, or sulfur hexafluoride stabilized in a phospholipid membrane. The bubbles oscillate when exposed to the ultrasound beam (they are being compressed by the effect of positive pressure created by the ultrasound waves and they expand in the negative pressure phase). The compression of the gas is greater than expansion which creates a non-linear response (echo). This greatly affects ultrasound backscatter and increases vascular contrast in a similar manner to intravenous contrast agents used in CT and MRI 2. Examples of ultrasound contrast agents available commercially include SonoVue® (Bracco).
Contrast-enhanced ultrasound has the advantage over contrast-enhanced MRI and CT in patients with contraindications such as renal failure or iodinated contrast allergy. CEUS also allows for dynamic and repeat examinations.
An individual microbubble is estimated to measure approximately 6 micrometres, compared to a human erythrocyte measuring approximately 9 micrometres. Microbubbles are therefore not filtered in the lungs since they are equivalent in size to red blood cells. Microbubbles are different from the agitated saline used in echocardiographic "bubble studies".
Non-targeted contrast-enhanced ultrasound
The more common method
- dynamic evaluation of the vascularity of a target lesion, most commonly in the liver or kidney, may be useful in diagnosis
- used to measure organ perfusion, which can be useful in diagnosing diffuse processes (e.g. cirrhosis)
Targeted contrast-enhanced ultrasound
Contrast agents designed to bind to specific molecules, which are then targeted at tissues expressing that substance.
CEUS artefacts
In very rare cases CEUS contrast agents may cumulateaccumulate in the liver and cause inhomogeneous, often confluous hyperechogenicities, or acoustic shadowing without associated clinical symptoms. This is termed prolonged heterogeneous liver enhancement and is a benign, self-limited complication.
-</ul><h5>Targeted contrast-enhanced ultrasound</h5><p>Contrast agents designed to bind to specific molecules, which are then targeted at tissues expressing that substance.</p><h5>CEUS artefacts</h5><p>In very rare cases CEUS contrast agents may cumulate in the liver and cause inhomogeneous, often confluous hyperechogenicities, or acoustic shadowing without associated clinical symptoms. This is termed <a href="/articles/prolonged-heterogeneous-liver-enhancement-ceus">prolonged heterogeneous liver enhancement</a> and is a benign, self-limited complication. </p><p> </p>- +</ul><h5>Targeted contrast-enhanced ultrasound</h5><p>Contrast agents designed to bind to specific molecules, which are then targeted at tissues expressing that substance.</p><h5>CEUS artefacts</h5><p>In very rare cases CEUS contrast agents may accumulate in the liver and cause inhomogeneous, often confluous hyperechogenicities, or acoustic shadowing without associated clinical symptoms. This is termed <a href="/articles/prolonged-heterogeneous-liver-enhancement-ceus">prolonged heterogeneous liver enhancement</a> and is a benign, self-limited complication. </p><p> </p>
Unable to process the form. Check for errors and try again.